Liu Xiaomei, Wang Yanyang, Liu Min, Zhang Yu, Wu Qiang, Wang Qian
Rehabilitation Medicine Center, Institute of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Key Laboratory of Rehabilitation Medicine in Sichuan Province, West China Hospital, Sichuan University, Chengdu, 610041, China.
J Orthop Surg Res. 2025 Feb 28;20(1):214. doi: 10.1186/s13018-025-05612-7.
Adolescent idiopathic scoliosis (AIS) is one of the most prevalent spinal abnormalities. Core stabilization exercise (CSE) has become a common approach in the treatment of AIS. However, the efficacy of CSE in AIS remains a subject of debate.
To determine the efficacy of CSE in the patients with AIS in comparison with different intervention programs.
A comprehensive search was conducted across PubMed, Embase, The Cochrane Library, Web of Science, Wan Fang, Wei Pu, and CNKI databases, encompassing literature from their inception through December 31st, 2024. Two independent reviewers screened the studies, with inter-rater agreement evaluated via kappa scores. Randomized control trials that focus on the efficacy and safety of CSE in AIS population were included in this systematic review. The risk of bias assessment was performed utilizing the National Institutes of Health Quality Assessment Tools (NIH-QAT). After quality assessments and information extraction, the meta-analysis was conducted with Review manager and the standard mean difference (SMD) was pooled among the measurement data derived from different studies. Cobb angle, angle of trunk rotation, apical vertebral rotation, Walter Reed Visual Assessment Scale, Posterior Trunk Symmetry Index, forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/FVC, SRS-22,, were focused as outcomes.
A total of 10 studies involving 449 subjects were included in this systematic review. The average Cobb angle was 22.86° ± 8.79°, and the intervention duration varied from 8weeks to 6months. The kappa score was 0.93. Subgroup analyses were performed based on the different control groups, National Institutes of Health Quality Assessment Tools (NIH-QAT) results, and intervention durations. The results indicated that CSE could have greater effect sizes than the blank control group on Cobb angle (MD = -4.37, P < 0.05), angle of trunk rotation (MD = -1.07, P < 0.05), apical vertebral rotation (MD = -0.44, P < 0.05), quality of life as SRS-22 (MD = 0.22, P < 0.05). Notably, the efficacy of CSE appears to be weaker than that of the three-dimensional exercise group in terms of Cobb angle (MD = 3.95, P < 0.05), angle of trunk rotation (MD = 1.69, P < 0.05) and WASRS scores (MD = 0.89, P < 0.05). Other subgroup analyses yielded no statistically significant differences.
The present study showed that core stabilization exercise may be beneficial for the patients with mild to moderate adolescent idiopathic scoliosis, albeit less effective than three-dimensional exercises following short-term follow-up. The evidence on the efficacy of CSE is limited due to heterogeneity, small sample sizes, and multiple comparisons. The clinical trials focusing on patient compliance and training quality with long-term follow-up are warranted.
CRD 42022367714.
青少年特发性脊柱侧凸(AIS)是最常见的脊柱畸形之一。核心稳定性训练(CSE)已成为治疗AIS的常用方法。然而,CSE治疗AIS的疗效仍存在争议。
与不同干预方案相比,确定CSE对AIS患者的疗效。
全面检索了PubMed、Embase、Cochrane图书馆、Web of Science、万方、维普和知网数据库,纳入自数据库建立至2024年12月31日的文献。两名独立评审员筛选研究,通过kappa评分评估评分者间的一致性。本系统评价纳入了关注CSE在AIS人群中疗效和安全性的随机对照试验。使用美国国立卫生研究院质量评估工具(NIH-QAT)进行偏倚风险评估。在质量评估和信息提取后,使用Review manager进行荟萃分析,并汇总不同研究测量数据中的标准均数差(SMD)。以Cobb角、躯干旋转角度、顶椎旋转、沃尔特·里德视觉评估量表、后躯干对称指数、用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、FEV1/FVC、SRS-22等为结局指标。
本系统评价共纳入10项研究,涉及449名受试者。平均Cobb角为22.86°±8.79°,干预持续时间为8周至6个月。kappa评分为0.93。根据不同对照组、美国国立卫生研究院质量评估工具(NIH-QAT)结果和干预持续时间进行亚组分析。结果表明,与空白对照组相比,CSE在Cobb角(MD=-4.37,P<0.05)、躯干旋转角度(MD=-1.07,P<0.05)、顶椎旋转(MD=-0.44,P<0.05)、SRS-22生活质量(MD=0.22,P<0.05)方面可能具有更大的效应量。值得注意的是,在Cobb角(MD=3.95,P<0.05)、躯干旋转角度(MD=1.69,P<0.05)和WASRS评分(MD=0.89,P<0.05)方面,CSE的疗效似乎弱于三维运动组。其他亚组分析未产生统计学显著差异。
本研究表明,核心稳定性训练可能对轻至中度青少年特发性脊柱侧凸患者有益,尽管在短期随访后其效果不如三维运动。由于异质性、样本量小和多次比较,关于CSE疗效的证据有限。有必要开展关注患者依从性和训练质量的长期随访临床试验。
PROSPERO注册号:CRD 42022367714。